CAS RN: 193884-53-6
APS-5
Product Availability
Choose a grade to view its available package options.
3 package records3 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250210 |
250mg |
In stock |
| Inquiry |
| Batchno.20260123 |
50mg |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260225 |
100mg / 250mg / 1g |
Confirm by inquiry |
Shanghai, Shandong | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: ≥95%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 193884-53-6
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥95% |
2
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
≥95% |
2
In Stock
|
Beijing |
Inquiry |
| 1g |
≥95% |
2
In Stock
|
Shanghai |
Inquiry |
193884-53-6 / disodium;[(4-chlorophenyl)sulfanyl-(10-methylacridin-9-ylidene)methyl] phosphate
Standard CAS: 193884-53-6
Multi CAS: No
Basic Information
CAS
193884-53-6
Multi CAS
No
Molecular Formula
C21H15ClNNa2O4PS
Molecular Weight
489.800000
Exact Mass
488.994332
SMILES
CN1C2=CC=CC=C2C(=C(OP(=O)([O-])[O-])SC3=CC=C(C=C3)Cl)C4=CC=CC=C41.[Na+].[Na+]
InChI
InChI=1S/C21H17ClNO4PS.2Na/c1-23-18-8-4-2-6-16(18)20(17-7-3-5-9-19(17)23)21(27-28(24,25)26)29-15-12-10-14(22)11-13-15;;/h2-13H,1H3,(H2,24,25,26);;/q;2*+1/p-2
InChIKey
NDPRDNBCONYNMF-UHFFFAOYSA-L
Computed Properties
Structural Parameters
Heavy atom count
31
Aromatic heavy atom count
18
Fraction Csp3
0.05
Rotatable bonds
4
H-bond acceptors
6
Molar refractivity
112.97
TPSA
75.66
LogP / Solubility
WLOGP
-1.22
MLOGP
-1.04
XLogP3
-1.22
Consensus LogP
-1.16
Log S (ESOL)
-2.28
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.7
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.31
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.57
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3